| Literature DB >> 25635182 |
Pankaj Kumar1, Masanao Murakami1, Rajeev Kaul1, Abhik Saha1, Qiliang Cai1, Erle S Robertson2.
Abstract
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus associated with a large number of lymphoid and epithelial malignancies. As a successful pathogen it has co-evolved with its human host for millions of years. EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, a small subset of viral proteins is expressed. These proteins are essential for maintenance of the EBV genome as well as the deregulation of various signaling pathways that facilitate the proliferation and survival of the infected cells. Epstein-Barr nuclear antigen (EBNA)3C is one of the latent proteins shown to be essential for transformation of primary human B lymphocytes in vitro. EBNA3C primarily functions as a transcriptional regulator by interacting with a number of well known cellular and viral transcriptional factors. We have recently identified several binding partners for EBNA3C including proteins that regulate cell cycle and chromatin remodeling. We are actively engaged in discerning the biological significance of these interactions. This review summarizes our current understanding of how EBNA3C usurps cellular pathways that promote B-cell transformation.Entities:
Keywords: Epstein–Barr nuclear antigen 3C; Epstein–Barr virus; cell cycle; latency; transcriptional regulator; viral transformation
Year: 2009 PMID: 25635182 PMCID: PMC4307939 DOI: 10.2217/17460794.4.1.79
Source DB: PubMed Journal: Future Virol ISSN: 1746-0794 Impact factor: 1.831